Freenome News and Activities

Freenome is one of the...

• TOB Iconic 10,000;
• Unicorn.

View the org chart displaying its 33 main executives

Most searched biographies at Freenome

• Aaron Elliott, Chief Executive Officer
• Moritz Hartmann, Director and Chairman of the Board
• Josh Lauer, Director

Popular executive movements at Freenome

• Rob Guigley has joined the company as Chief Commercial Officer  (posted on November 11 2025).

Create your alert
to follow the executive moves at Freenome.

Freenome has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Freenome

• Freenome’s SimpleScreen™ CRC Blood-Based Test Included in Updated ACS Colorectal Cancer Screening Guideline
• Freenome Reports Data for Multiomic Blood-Based Screening Test for Lung Cancer
• Freenome Announces Expanded Artificial Intelligence and Deep Learning Initiatives Accelerated by NVIDIA, to Advance Personalized Multi-Cancer Detection
• Freenome Delivers Improved Performance in Its Colorectal Cancer Blood Test with Sensitivity of 85% for CRC and 22% for Advanced Precancerous Lesions
• Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform
• Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S.
• Freenome Appoints Industry Veteran Rob Guigley as Chief Commercial Officer to Drive Commercial Strategy, As Agreement with Exact Sciences Clears Antitrust Review
• Freenome Announces Exclusive License Agreement with Exact Sciences to Commercialize Freenome’s Blood-Based Screening Test for Colorectal Cancer
• Freenome Announces JAMA Publication of Data from Pivotal Study of its Blood-Based Test for Colorectal Cancer
• Freenome Appoints Linh H. Le as Chief Financial Officer
• View more press releases Close

Social media about Freenome

• Freenome on Wikipedia, Google News & Yahoo Finance
• Freenome on LinkedIn, X (Twitter) & YouTube